AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
1.200
-0.005 (-0.41%)
Jan 28, 2026, 10:36 AM EST - Market open
AN2 Therapeutics Market Cap
AN2 Therapeutics has a market cap or net worth of $32.88 million as of January 28, 2026. Its market cap has decreased by -11.96% in one year.
Market Cap
32.88M
Enterprise Value
-28.90M
1-Year Change
-11.96%
Ranking
Category
Stock Price
$1.20
Market Cap Chart
Since the IPO on March 25, 2022, AN2 Therapeutics's market cap has decreased from $281.10M to $32.88M, a decrease of -88.30%. That is a compound annual growth rate of -42.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 33.02M | 5.70% |
| Dec 31, 2025 | 31.24M | -24.24% |
| Dec 31, 2024 | 41.23M | -93.23% |
| Dec 29, 2023 | 609.40M | 229.57% |
| Dec 30, 2022 | 184.91M | -34.22% |
| Mar 25, 2022 | 281.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cue Biopharma | 34.67M |
| Evaxion | 33.69M |
| Pluri | 33.13M |
| Werewolf Therapeutics | 32.75M |
| Dyadic International | 32.57M |
| Skye Bioscience | 32.38M |
| Outlook Therapeutics | 32.25M |
| Genenta Science | 31.16M |